Fluticasone propionate / azelastine (Dymista)
- BNF:
- 12.2.1
- Status:
- Grey
- Decision Date:
- March 2016
Comments
GREY: for moderate to severe seasonal and perennial allergic rhinitis (aged 12 years or over) following the Allergic Rhinitis in adults and adolescents over 12 years of age (Decision date - May 2019)
Grey Drug Classifications
- 1: Lack of data on effectiveness compared with standard therapy
- 5: Less cost-effective than current standard therapy
search again